Cannabis Law Report

NOVEMBER 15, 2021

Lab Testing and Product Safety. Impaired Driving and Traffic Safety. Environment and Energy. Their work informed several letters to Congress regarding national cannabis policy priorities and comments on proposed federal legislation to legalize cannabis federally. Social and Economic Equity. Medical Use and Research.

Compliance 98

Compliance Compliance Topical Programs 98

PrestoDoctor

OCTOBER 23, 2023

It’s also worth mentioning that the safety of THCjd depends on various factors. Research on THCjd is still limited, and therefore, its safety profile is not yet fully understood. However, further studies are necessary to determine its safety, dosage , and long-term effects. Is THCjd Safe?

Cannabinoids 98

Cannabinoids Research and Development Safety THC 98

The Blunt Truth

AUGUST 22, 2022

Employers can maintain a reasonable drug-free workplace policy that: Requires post-accident or reasonable suspicion drug testing of all employees or random drug testing of safety-sensitive workers; Is necessary to comply with federal law or a federal contract or funding agreement, if applicable to the employer; or.

Safety 111

Safety Environment Policy Recreational 111

Veriheal

DECEMBER 4, 2023

Notably, President Ronald Reagan’s administration implemented the Drug-Free Workplace Act of 1988 , which mandated drug-free workplace environments. At that time, illicit substances were perceived as a significant threat to both workplace productivity and safety.

Policy 119

Policy Safety Treatment Business 119

Cannabis Law Report

JULY 23, 2021

A requirement that employers establish an awareness program to inform employees of the dangers of drugs and alcohol in the workplace. The employer sent the employee a letter that informed him of the drug test result and advised that he had the right to a confirmatory test provided that he paid for it. Charles Gabus Ford, Inc.

Safety 81

Safety Policy Compliance Compliance 81

Cannabis Law Report

JUNE 24, 2021

To ensure continued safety during the Covid-19 pandemic, the location plans to offer pickup and delivery services, through our best-in-class ecommerce platform, creating a seamless purchasing experience. Safety is top priority at Choom. Forward-looking information. Choom Holdings Inc. Corey Gillon, CEO. T: 604.683.2509.

eCommerce 78

eCommerce Retail Environment Safety 78

United Patients Group

NOVEMBER 16, 2023

At United Patients Group , we’re committed to providing educational, informative, and reliable resources that guide you through the ever-evolving world of medical marijuana and related topics. Third-Party Tested : Ensure the product has been lab-tested for quality, potency, and safety by an independent, third-party lab.

Pets 105

Pets CBD Digestion Tincture 105

Illinois News Joint

NOVEMBER 27, 2024

And check our Dispensary Directory for more information. AuraLight mission statement is to empower the “community with trusted cannabis expertise and high-quality products, fostering a welcoming environment built on knowledge, trust, and teamwork.

Dispensary 111

Dispensary Environment Recreational Patients 111

The Cannigma

AUGUST 31, 2021

Barely a quarter of cannabis users trust their doctor to provide them with reliable information about medical cannabis and how to use it to treat their medical or health conditions, according to a recent survey. People want to trust their doctors, but doctors need knowledge.

Education 105

Education Clinical Trials Medicine Policy 105

Cannabis Law Report

JULY 29, 2021

Canada’s Cannabis Regulation- Decoding The Information. It will be mostly towards ensuring the safety of the public and to curb any illegal market. All in all, they want to create a positive environment around cannabis so that people who wish to use it don’t fall under any skepticism. So, let’s begin!

Research and Development 105

Research and Development Legalization Environment Conditions 105

CannaMD

MARCH 19, 2020

We look forward to providing telehealth services as allowed by law, and will update this post with more information as details become available. We pride ourselves on the cleanliness and sanitary conditions of our facilities and dispensaries and have an ongoing Safety Policy Plan to assure sanitary production facilities. ALTMED (MÜV).

Policy 98

Policy Dispensary Patients Safety 98

Cannabis Law Report

JUNE 24, 2021

provides regulatory information assistance. Analyse routine information presented as part of licence and permit applications to. in a high pressure environment with critical deadlines. Experience in a regulatory environment. These requirements are based on the information provided to you as. Key Responsibilities.

Environment 61

Environment Research and Development Compliance Compliance 61

Cannabis Law Report

MARCH 4, 2022

Get more information about these proposed changes: View the rulemaking documents – includes the proposed text of regulations, initial statement of reasons and notice of proposed rulemaking. DCC also held a webinar on Thursday, March 3, with information about the rulemaking process and a high-level preview of proposed regulatory changes.

Environment 96

Environment Cannabis Medicine Safety 96

The Blunt Truth

AUGUST 13, 2019

CBD is “thriving” in the current regulatory environment, but is it doing so illegally? On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety. As former U.S. The FDA needs to act.”

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

Cannabis Law Report

JUNE 17, 2021

Patients are looking to their medical providers for information on cannabis safety, potential for interactions with pharmaceuticals, and therapeutic applications. However, the existing legal environment significantly hinders the ability of clinicians to engage with cannabis research or offer clear guidance.

Policy 61

Policy Research and Development Medicine Safety 61

Veriheal

MARCH 18, 2021

However, the team explains that the safety and efficacy of cannabis as a chronic treatment needs to be better understood along with the interactions between cannabis and pharmaceutical medications, in the likely event that the Alzheimer’s patient is on multiple other medications. What Did The Study Find?

CBD 109

CBD Research and Development Pets Treatment 109

Cannabis Law Report

SEPTEMBER 11, 2021

The position provides daily oversight of complaints of product safety issues, non-compliance, and patient safety issues, qualified personnel registration, as well as application and renewal process for all licenses issued by the Commission. Monitor and evaluate performance of the program area and subordinate staff.

Compliance 105

Compliance Compliance Seed-To-Sale Data 105

Cannabis Law Report

AUGUST 19, 2021

In these letters, C3 highlighted: The barriers for social progress and equity within the legal cannabis environment, especially for BIPOC individuals. C3 recently wrote letters to each federal party leader posing nine questions to determine their party’s commitment to the Canadian cannabis sector.

Advocacy 105

Advocacy Research and Development Cannabis Environment 105

Peninsula Alternative Health

MARCH 22, 2023

Additionally, everything will be tracked from seed to sale as it is now, ensuring that consumers can have confidence in the quality and safety of the product they are buying. Instead, all marijuana products will be tested at a state-owned lab, ensuring consistent quality and safety standards across the board.

Patients 98

Patients Legalization Seed-To-Sale Dispensary 98

Cannabis Law Report

JANUARY 24, 2019

In June 2017, the California State Legislature passed budget trailer bill, Senate Bill 94, the Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA) to integrate MCRSA with AUMA into a consolidated system for the regulation, licensing, taxation, and enforcement for both medicinal and adult-use commercial cannabis activities.

Safety 65

Safety Environment Cultivation Retail 65

Veriheal

JANUARY 18, 2024

For example, teaching patients about the endocannabinoid system, terpenes, various cannabinoids, and consumption methods empowers them to make informed decisions catering to their unique health concerns. They strive to create an accepting and understanding environment.

Education 116

Education Therapy Patients Research and Development 116

Cannabis Law Report

JUNE 3, 2021

SugarTop Buddery has prioritized pesticide-free cultivation since our brand’s inception, and we’re proud to announce our partnership with Terra Vera to utilize a sustainable, environmentally mindful crop management solution that does not compromise the safety of our consumers, growers, or environment.”. About SugarTop Buddery.

Environment 72

Environment Supply Chain Cultivation Strains 72

Cannabis Law Report

JULY 28, 2021

More information about the organization is available at [link]. MAPS PBC strives to continually improve upon the supportive, equitable and accessible work environment. Ensure tracking and archiving of regulatory documentation lifecycle: submissions, correspondence, and related information for various regulatory applications.

Clinical Trials 81

Clinical Trials Research and Development Data Environment 81

Cannabis Law Report

JUNE 25, 2021

DENVER–(BUSINESS WIRE)– #CDPHE — Botanacor Laboratories announced that it is the first certified lab by the Colorado Department of Public Health & Environment (CDPHE) to test Colorado-manufactured industrial hemp products intended for human use or consumption. We’re honored and ready.

Hemp 63

Hemp Supply Chain Compliance Compliance 63

MMJ Recs

JUNE 30, 2024

Ensuring the potency and safety of cannabis edibles and oils is paramount for patients reliant on their therapeutic benefits. Understanding the different types of edibles available can help patients make informed choices based on their individual needs and preferences.

Edibles 111

Edibles Oil Packaging Patients 111

Cannabis Law Report

JULY 7, 2021

We remain encouraged as we continue our evaluations of MYMD-1 for efficacy and safety – especially as studies continue to suggest we may be able to address many of the concerns that are associated with the current drugs on the market today in these disease areas.”. For more information, visit www.mymd.com. Eurofins is testing for life.

Pharmaceutical 81

Pharmaceutical Data Clinical Trials Research and Development 81

Cannabis Law Report

JULY 13, 2022

The Department took steps this year to deliver on the promise of consolidation, establishing regulatory reforms that streamline requirements for cannabis licensees, unifying department operations to more efficiently support the entire supply chain, centralizing complaint reporting, and enhancing access to public resources and information.

Compliance 52

Compliance Compliance Supply Chain Environment 52

Pot Valet

NOVEMBER 10, 2024

Having accurate data available when you need it informs important decisions. It helps them to thrive in a complicated and ever-changing retail environment. It simplifies weed life, while greatly improving safety and compliance. Assured Inventory Control Pot Valet’s innovative software tracks stock levels for you in real time.

Dispensary 87

Dispensary Compliance Compliance Programs 87

MMJ Recs

JULY 11, 2024

In this article, we explore the role of medical marijuana in addressing insomnia, examining its effectiveness, safety considerations, legal aspects, and practical considerations for patients and healthcare providers. Sleep hygiene practices, such as maintaining a consistent sleep schedule, creating a conducive sleep environment (e.g.,

Sleep 111

Sleep Treatment Therapy Research and Development 111

Cannabis Law Report

MARCH 1, 2022

A fast-paced environment where you’ll work on a wide range of topics. Focus will be on IND/CTA filings and associated interactions, and may include safety reports, protocols, information amendments, responses to requests for information, IND Annual Reports/DSURs, and new investigator amendments. Position: Full-time.

Clinical Trials 52

Clinical Trials Environment Pharmaceutical Programs 52

MMJ Recs

NOVEMBER 17, 2023

Support for Patient Well-Being The availability of medical marijuana in local communities fosters an environment of support for patients seeking alternative treatments. Over time, Maryland has refined its approach to ensure the accessibility and safety of MMJ for its residents.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JUNE 15, 2021

The position provides daily oversight of complaints of product safety issues, non-compliance, and patient safety issues, qualified personnel registration, as well as application and renewal process for all licenses issued by the Commission. Monitor and evaluate performance of the program area and subordinate staff.

Compliance 81

Compliance Compliance Seed-To-Sale Data 81

Cannabis Law Report

JULY 28, 2021

This position requires a team player with strong policy, writing and organizational skills, a strong work ethic, an ability to think quickly in a fast-paced environment, and attention to detail. Handle and access confidential information and protect confidentiality of the data shared with the office. Essential Job Functions.

Policy 81

Policy Legislation Research and Development Data 81

Kind Meds (Cannabis Education Blog)

OCTOBER 20, 2021

In order to remain as well-informed as possible about how you interact with and consume cannabis , we believe that it is a good idea to understand how each important part of the plant is used. In the marijuana community, dabbing has quickly become a practice that is both popular and controversial, due to its potential safety risks.

Trichome 105

Trichome Terpenes Extraction Concentrates 105

Cannabis Law Report

OCTOBER 2, 2021

A fast-paced environment where you’ll work on a wide range of topics. Focus will be on IND/CTA filings and associated interactions, and may include safety reports, protocols, information amendments, responses to requests for information, IND Annual Reports/DSURs, and new investigator amendments. San Diego, United States.

Clinical Trials 52

Clinical Trials Environment Pharmaceutical Programs 52

Medicinal Genomics

MARCH 16, 2021

(MGC), a pioneer in harnessing cannabis genomics to improve the agricultural productivity, safety, and transparency of cannabis, today announced an agreement with Soquimica to be its distribution partner in Portugal. Information about Soquimica is available at www.soquimica.pt. ” Rita Gonçalves, General Manager, Soquimica.

Medicine 52

Medicine Chronic Pain Environment Safety 52

Miss Marijuana

JANUARY 30, 2025

Setting Up a Calm Environment Your environment plays a big role in your mental state! Small changes in your environment can make a huge difference! Cannabis can help, but so can creating a calm environment, combining treatments, and making small lifestyle tweaks. Safety first! Let’s explore the potential downsides!

Treatment 52

Treatment Microdosing Indica Terpenes 52